JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology world-wide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers.
JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer. The journal is published online each week, with most major manuscripts published online first, followed by a complete print issue published every month.
The Editor in Chief of JAMA Oncology is Mary L. (Nora) Disis, MD, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at the University of Washington, and a member of the Fred Hutchinson Cancer Research Center.
Features of JAMA Oncology include the following:
- Leading clinical research
- Timely viewpoints and clinically relevant reviews
- Educational content for those engaged in oncology research, practice, and training
- Enhanced reader access through related commentary, author audio interviews, e-mail alerts, Facebook, Twitter, other social media, and Topic Collections
About the EditorsEditor
Mary L. (Nora) Disis, MD Deputy Editors
Lee M. Ellis, MD, Houston, Texas
Charles R. Thomas Jr, MD, Portland, OregonAssociate Editor for Statistics
Yu Shyr, PhD, Nashville, TennesseeAssociate Editor for Editorials, Viewpoints, and Commentaries
George W. Sledge Jr, MD, Stanford, CaliforniaAssociate Editor for Reviews and CME
Monica Morrow, MD, New York, New YorkWeb Editor
Howard (Jack) West, MD, Seattle, Washington